In renal cell carcinoma (RCC), tumor-associated macrophages (TAMs) (predominantly M2-like) facilitate immune evasion by promoting immunosuppression and upregulating PD-L1 expression within the tumor microenvironment. This evidence concerns the gene CD274 and neoplasm.